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Epidemiologic surveillance study was conducted in southern Japan to determine the
antimicrobial resistance phenotypes and characterize the β-lactamase genes and the
plasmids harboring these genes in Salmonella enterica serovar Infantis (S. Infantis) isolates
from broilers. Between January, 2007 and December, 2008, a total of 1,472 fecal samples
were collected and examined at the Laboratory of Veterinary Public Health, Kagoshima
University, Japan. In 93 (6.3%) isolates recovered, 33 (35.5%) isolates showed resistance
to cefotaxime, an extended-spectrum cephalosporin (ESC), conferred by TEM-20, TEM-52
and CTX-M-25 extended-spectrum β-lactamases (ESBLs). In addition to ESC-resistance,
eight (8.6%) isolates exhibited resistance to cefoxitin mediated by CMY-2 AmpC
β-lactamase. Plasmid analysis and polymerase chain reaction replicon typing revealed
the blaTEM−20 and blaCMY 2 genes were associated with IncP plasmids, blaTEM was− −52
linked with a non-typable plasmid and blaCTX−M−25 was carried by an IncA/C plasmid.
Non-β-lactam resistance to streptomycin, sulfamethoxazole, and oxytetracycline encoded
by the aadA1, sul1, and tet (A) genes, respectively, was found in 86 (92.5%) isolates.
Resistance to kanamycin and oﬂoxacin was exhibited in 12 (12.9%) and 11 (11.8%)
isolates, respectively, the former was mediated by aphA1-Iab. These data indicate that
S. Infantis isolates producing ESBLs and AmpC β-lactamase have spread among broiler
farms in Japan. These data demonstrated that the incidence of ESC-resistant S. Infantis
carrying blaTEM−52 remarkably increased and S. Infantis strains harboring blaCMY−2,
blaTEM 20, or bla genes− CTX−M−25 emerged from broilers in Japan for the ﬁrst time in 2007
and 2008.
Keywords: antimicrobial resistance, β-lactamase gene, broiler, extended-spectrum cephalosporin, Salmonella
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INTRODUCTION
Non-typhoidal Salmonella enterica serovars (Salmonella) are a
major cause of bacterial food-borne diseases world-wide (Majow-
icz et al., 2010). The food poisoning statistics in Japan show that
bacterial food poisoning patients during the year 2008 num-
bered at 10,331 and Salmonella were the leading etiological
agents accounting for 24.7% of the cases [http://idsc.nih.go.jp/
iasr/29/342/graph/t3421.gif]. Poultry products are important
vehicles in the transmission, and have been incriminated in several
Salmonella outbreaks (Kimura et al., 2004; Chittick et al., 2006).
Since the late 1990s, Salmonella enterica serovar Infantis (S. Infan-
tis) has been the commonest serovar of Salmonella isolated from
both broiler ﬂocks and retail chicken meat in Japan (Asai et al.,
2007b; Iwabuchi et al., 2011).
The emergence of multidrug-resistant Salmonella has become
a serious global health problem because antimicrobial treat-
ment is lifesaving for invasive infections, particularly in neonates
of <1 year of age. Preventive antimicrobial treatment is also
generally given to patients suffering from immunosuppressive or
other predisposing conditions (Hohmann, 2001). The options
of ﬁrst-line therapy for Salmonella infection include ampicillin
(AMP), sulfamethoxazole-trimethoprim, ﬂuoroquinolones, and
extended-spectrum cephalosporins (ESCs). ESCs are among the
preferred drugs because of resistance to the other aforementioned
drugs is relatively frequent in Salmonella isolates (Hohmann,
2001). At present, ESC-resistance in Salmonella is mainly
attributed to the acquisition of plasmid-mediated extended-
spectrum β-lactamases (ESBLs) andAmpC β-lactamases (Bonnet,
2004; Arlet et al., 2006).
Salmonella carrying the blaCMY−2 gene were recently recovered
frombovine and porcine salmonellosis cases (Dahshan et al., 2010;
Sugawara et al., 2011). Besides, S. Infantis isolates harboring the
blaTEM−52 gene were reported from broilers for the ﬁrst time in
the year 2004 (Shahada et al., 2010a). Thus, a major concern has
been increased prevalence of resistance to ESCs noted in S. Infantis
isolates. This study was conducted to determine the antimicrobial
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resistance phenotypes and characterize the β-lactamase genes and
the plasmids harboring these genes in S. Infantis isolated from
broiler ﬂocks.
MATERIALS AND METHODS
BACTERIAL ISOLATES
Between January, 2007 and December, 2008, a total of 1,472 cecal
specimens derived from 92 broiler ﬂocks (ca. 10,000 birds per
ﬂock) were collected from a poultry processing plant located in
the southern part of Japan. Usually, 16 samples per ﬂock were
randomly selected fortnightly. The isolation, identiﬁcation and
serotyping of S. Infantis isolates were performed at the Labora-
tory of Veterinary Public Health, Kagoshima University, Japan as
previously described (Shahada et al., 2008).
DETERMINATION OF MINIMUM INHIBITORY CONCENTRATIONS
Antimicrobial susceptibility testing was assayed by the agar dilu-
tion method on Mueller-Hinton (MH) agar (Oxoid Ltd., Bas-
ingstoke, Hampshire, England) plates according to the National
Committee for Clinical and Laboratory Standards guidelines
(National Committee for Clinical Laboratory Standards, 2001).
S. Infantis isolates were tested for sensitivities to AMP, cefo-
taxime (CTX), cefoxitin (FOX), chloramphenicol (CHL), strep-
tomycin (STR), sulfamethoxazole (SUL), oxytetracycline (TET),
kanamycin (KAN), and oﬂoxacin (OFX). The MIC range was set
at 0.125–512 μg/ml for all tested antimicrobial agents. The MIC
breakpoints were interpreted according to the new criteria estab-
lished by the Clinical and Laboratory Standards Institute (2012).
Escherichia coli (E. coli) ATCC 25922 and Staphylococcus aureus
ATCC29213 were used as quality control strains.
DOUBLE-DISK SYNERGY ASSAY
Thedouble-disk synergy testingwas conducted to screen for ESBLs
and AmpC β-lactamases as previously described (Shahada et al.,
2010a). This test was performed as a standard Kirby-Bauer disk
diffusion assay on MH agar (Oxoid) plates.
DETECTION OF RESISTANCE DETERMINANTS
All DNA templates were prepared using the InstaGene Matrix
kit (Bio-Rad Laboratories, Hercules, CA, USA). Detection of
resistance genes was performed by polymerase chain reaction
(PCR). The ampliﬁcation reactions were carried out using primers
and conditions as previously described (Dahshan et al., 2010;
Shahada et al., 2010b). Brieﬂy, the targets were as follows:
blaTEM, blaOXA, blaPSE, blaSHV, blaCTX−M−1 group, blaCTX−M−2
group, blaCTX−M−25, and Toho-1 encoding for penicillinases;
blaCIT, blaCMY−2, blaDHA, blaFOX, blaMOX, blaACC, and blaEBC
encoding for cephalosporinases; tet(A), tet(B), and tet(G) medi-
ating tetracycline efﬂux proteins; aadA1 and aadA2 encoding for
resistance to STR and spectinomycin; sul1 conferring resistance to
SUL; and aphA1-Iab encoding for resistance to KAN.
Whenβ-lactamase-encoding geneswere positive followingPCR
ampliﬁcation, obtained products were directly sequenced using a
BioDye Terminator version 3.1 Ready Reaction sequencing kit and
ABI 3100 automated DNA sequencer (Applied Biosystems, Foster
City, CA, USA). The DNA alignments and deduced amino acid
sequences were examined using the BLAST program (National
Center for Biotechnology Information, USA).
PLASMID ANALYSIS
All S. Infantis isolates were examined for the carriage of plasmids
by employing the alkaline lysis method as previously described
(Kado and Liu, 1981). The molecular size of plasmids was
determined by using the standard Salmonella enterica serovar
Choleraesuis ATCC 7001 (50 kbp) and S. Typhimurium DT104
strain 300-98 (90kbp). Theplasmid sizewas estimatedby graphing
the molecular size of standard strains versus the distance traveled
from the wells using logistic graph paper. Conjugation experi-
ments were performed as described previously (Shahada et al.,
2010a). In brief, S. Infantis donor isolates and rifampicin-resistant
E. coli DH5α recipient derivatives were used for conjugal mating.
Conjugants were selected onto deoxycholate hydrogen sulﬁde lac-
tose agar containing 128 μg/ml rifampicin and 128 μg/ml AMP,
followed by antimicrobial testing and the detection of transferred
resistance genes as above. Plasmids were characterized by the PCR-
based replicon typing method as described previously (Carattoli
et al., 2005) to detect the plasmid types: IncI1, IncA/C, IncHI1,
IncHI2, IncN, IncX, IncW, IncY, IncP, IncT, IncFIIs, IncL/M,
IncFIA, IncFIB, IncFIC, IncFrepB, IncK/B, and IncB/O.
RESULTS
ANTIMICROBIAL RESISTANCE
S. Infantis isolates were recovered in 54 (58.7%) of 92 ﬂocks sur-
veyed and 93 (6.3%) of 1,472 samples examined. Antimicrobial
susceptibility proﬁles of the isolates are summarized in Table 1. Of
93 S. Infantis isolates recovered, 34 (36.5%) exhibited resistance
to AMP (MIC, 256 to >512 μg/ml), 33 (35.5%) showed resis-
tance to CTX (MIC, 4-256 μg/ml) and eight (8.6%) demonstrated
resistance to FOX (MIC, 32–128 μg/ml). From the 93 isolates
and with regard to non-β-lactam antibiotics, 86 (92.5%) isolates
exhibited resistance to STR (MIC, 16–512 μg/ml, conferred by
aadA1), SUL (MIC>512μg/ml, conferredby sul1) andTET (MIC,
64–512 μg/ml, conferred by tetA); 12 (12.9%) isolates showed
resistance to KAN (MIC, ≥512 μg/ml, conferred by aphA1); and
11 (11.8%) isolates demonstrated resistance to OFX (MIC, 2–
8 μg/ml). All 93 isolates were fully susceptible to CHL. On the
basis of resistance patterns, 11 phenotypes (A to K) were demon-
strated as depicted in Table 2. The most frequent pattern was
STR/SUL/TET (43 isolates) followedbyAMP/CTX/STR/SUL/TET
(14 isolates).
ESBL AND AMPC CHARACTERIZATION
Double-disk synergy testing revealed 25 ESBL- and eight AmpC
β-lactamase-producing S. Infantis isolates. TEM-type ESBL was
identiﬁed in 23 (24.7%) isolates, CTX-M-type ESBL was demon-
strated in one isolate and CMY-type AmpC β-lactamase was
detected in eight isolates. Nucleotide sequencing of PCR prod-
ucts conﬁrmed that the amplicons were blaTEM−52 (22 isolates),
blaTEM−20 (one isolate), blaCTX−25 (one isolate in combination
with blaTEM−52), and blaCMY−2 (8 isolates). Of 54 S. Infantis-
positive ﬂocks, As indicated in Table 3, S. Infantis isolates har-
boring blaTEM−1 were not detected during the present study; but,
they were found during 1998–2003 (one isolate) and 2004–2006
(17 isolates). On the other hand, isolates harboring blaTEM−52
were identiﬁed during 2004–2006 (11 isolates) and 2007–2008
(22 isolates). Isolates carrying the blaTEM−20, blaCTX−25, and
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Table 1 | Antimicrobial susceptibility among 93 Salmonella Infantis
isolates detected in this study
Antimicrobial
agent
MIC breakpoint
(μg/m/)
No. of resistant isolates (%)
This study Previous study
2007–2008 2004–2006a
AMP ≥32 34 (36.5) 29 (24.2)
CTX ≥4 33 (35.5) 11 (9.1)
FOX ≥32 8 (8.6) 0 (0)
CHL ≥32 0 (0) 0 (0)
STR ≥16 86 (92.5) 120 (100)
SUL ≥512 86 (92.5) 120 (100)
TET ≥16 86 (92.5) 120 (100)
KAN ≥64 12(12.9) 9 (7.5)
OFX ≥2 11(11.8) 25 (20.8)
CTX, cefotaxime; FOX, cefoxitin; CHL, chloramphenicol; STR, streptomycin; SUL,
sulfamethoxazole;TET, oxytetracycline; KAN, kanamycin; OFX, oﬂoxacin. (a) Cited
from the previous study (Shahada et al., 2010b)
blaCMY−2 genes were demonstrated during 2007–2008 study
period.
PLASMID CHARACTERIZATION
Three plasmid proﬁles were deﬁned among S. Infantis isolates.
Seventy isolates harbored ca. 180-kbp plasmids (proﬁle I), 22 iso-
lates carried two plasmids of ca. 50 and 180 kbp (proﬁle II), and
one isolate possessed three plasmids of ca. 50, 125, and 180 kbp
(proﬁle III; Figure 1). Isolates exhibiting resistance to ESCs dis-
played diverse proﬁles: Of 34 ESC-resistant S. Infantis isolates, 22
belonged to proﬁle II, 11 were classiﬁed into proﬁle I and one
isolate was categorized into proﬁle III (Table 2). PCR-based repli-
con typing revealed three kinds of plasmids. Large-size plasmids
(ca.180 kbp) were typed as IncP, intermediate-size plasmid (ca.
125 kbp)was typed as IncA/C and small plasmids (ca. 50 kbp)were
non-typable. Large-, intermediate- and small-size plasmids were
self-transmissible to E. coli recipient strain by conjugation. The
blaTEM−20 and blaCMY−2 genes were associated with large IncP
plasmids, blaCTX−M−25 was afﬁliated with intermediate IncA/C
plasmid and the blaTEM−52 gene was linked to small non-typable
plasmids.
DISCUSSION
The results obtained in this study show that resistance to ESCs
has increased to 35.5% from the previous 9.2% reported during
an earlier investigation (Shahada et al., 2010b). Other new ﬁnd-
ings include the detection of S. Infantis isolates harboring the
blaTEM−20, blaCTX−M−25, and blaCMY−2 genes. Demonstration of
these resistance traits in S. Infantis serovar is a rare phenomenon.
This is the ﬁrst report describing these mechanisms of ESC-
resistance exhibited by S. Infantis isolates derived from broilers.
Previous reports indicate that β-lactam resistance in broilers was
once mediated by blaTEM−1, a narrow-spectrum β-lactamase gene
that was demonstrated in one S. Infantis isolate recovered dur-
ing 1998–2003 (Shahada et al., 2006) and 14.2% of the isolates
obtained in 2004–2006 (Shahada et al., 2010a). Besides, during the
period of 2004–2006, resistance to ESCs mediated by blaTEM−52
was reported for the ﬁrst time from the broiler industry in Japan
(Shahada et al., 2010a).
Table 2 | Distribution of resistance phenotypes, plasmid profiles and β-lactamase phenotypes in Salmonella Infantis isolates
Resistance
pattern
Resistance phenotype Plasmid No. of
isolates
β-lactamase
phenotype
profile size (ca. kbp) replicon type
A AMP/CTX/FOX/STR/SUL/TET/KAN I 180 IncP 1 AmpC
B AMP/CTX/FOX/STR/SUL/TET I 180 IncP 7 AmpC
C AMP/CTX/STR/SUL/TET/OFX II 180, 50 IncP, Non-typable 4 ESBL
D AMP/CTX/STR/SUL/TET/KAN II 180,50 IncP, Non-typable 2 ESBL
E AMP/CTX/STR/SUL/TET I 180 IncP 2 ESBL
AMP/CTX/STR/SUL/TET II 180, 50 IncP, Non-typable 11 ESBL
AMP/CTX/STR/SUL/TET III 180, 125, 50 IncP, IncA/C, Non-typable 1 ESBL
F AMP/CTX II 180, 50 IncP, Non-typable 5 ESBL
G AMP/STR/SUL/TET I 180 IncP 1 -
H STR/SUL/TET/OFX I 180 IncP 7 -
I STR/SUL/TET/KAN I 180 IncP 7 -
J STR/SUL/TET I 180 IncP 43 -
K KAN I 180 IncP 2 _
AMP, ampicillin; CTX, cefotaxime; FOX, cefoxitin; CHL, chloramphenicol; STR, streptomycin; SUL, sulfamethoxazole; TET, oxytetracycline; KAN, kanamycin; OFX,
oﬂoxacin.
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Table 3 | Chronological change of β-lactamase genes in serovar Infantis
β-lactamase
gene (bla)
No. of isolates during the isolation period
1998–2003a 2004–2006b 2007–2008c
(178 isolates) (120 isolates) (93 isolates)
TEM-1 1 (0.7%) 17 (14.2%) 0 (0%)
TEM-52 0 (0%) 11 (9.2) 22 (24.4%)d
TEM-20 0 (0%) 0 (0%) 1 (1.8%)
CTX-M-25 0 (0%) 0 (0%) 1 (1.8%)
CMY-2 0 (0%) 0 (0%) 8 (8.6%)
aCited from the previous study (Shahada et al., 2006).
bCited from the previous study (Shahada et al., 2010b).
c This study.
d CTX-M-25 andTEM-52 were simultaneously identiﬁed in one isolate.
In the present study, we identiﬁed one S. Infantis isolate har-
boring the blaTEM−20 gene while other isolates had blaTEM−52.
It’s worth noting that the wild-type blaTEM−1 gene was not
detected during this study suggesting the likelihood of occur-
rence of point mutations which led to the emergence of observed
variants, blaTEM−20 and blaTEM−52. This hypothesis is sup-
ported by deduced amino acid sequence analysis which revealed
that the blaTEM−20 gene differs from blaTEM−1 by two substitu-
tions, Met182→Thr and Gly238→Ser; whereas the blaTEM−52
gene differs from blaTEM−1 by three substitutions, Glu104 Lys,
Met182→Thr, and Gly238→Ser (Arlet et al., 1999; Weill et al.,
2004). This phenomenon has the implications for bacterial adap-
tation mechanism because blaTEM−1 seems to have lost its ﬁtness
as a potential resistance trait necessary for survival of Salmonella.
Thus, point mutations have taken place as the evolutionary
FIGURE 1 |Three plasmid profiles obtained from S. Infantis isolates.
Lane M1 and M2 shows standard sizes of plasmids extracted from
S. Choleraesuis ATCC 7001 (50 kbp) and S. Typhimurium DT104 strain
300-98 (90 kbp), respectively. L1: IncP (ca. 180 kbp), L2: IncP (ca. 180 kbp)
and Untypable plasmid (ca. 50 kbp), L3: IncP (ca. 180 kbp), IncA/C (ca.
125 kbp), and Untypable plasmid (ca. 50 kbp).
adaptation mechanism crucial for successful colonization of the
broiler chicken intestinal tract.
In Japan, CTX-M-type ESBL-producing Enterobacteriaceae are
important nosocomial infectious agents raising considerable con-
cern in the public health community. Similarly, the detection of
CTX-M-2 and CTX-M-25 ESBL-producing E. coli isolates from
chickens affected with colibacillosis has raised concerns in the vet-
erinary public health community (Kojima et al., 2005; Asai et al.,
2011).We report for the ﬁrst time one S. Infantis isolate harboring
blaCTX−M−25 on IncA/C plasmid and blaTEM−52 on non-typable
plasmid. Because blaCTX−M−25 was initially demonstrated in E.
coli (Asai et al., 2011) a comprehensive molecular study is required
to determine the likely source and elucidate mechanisms involved
in collecting antimicrobial resistance traits and mobilizing them
across taxonomical borders.
To date, several reports have described the emergence of
AmpC β-lactamase-producing Salmonella derived from farm
animals affected with salmonellosis. One of the studies involv-
ing Salmonella enterica serovar Typhimurium (S. Typhimurium)
identiﬁed blaCMY−2 associated with self-transmissible IncI1-
Iγ and A/C plasmids (Sugawara et al., 2011). Another study
revealed a novel chromosomally integrated multi-drug resis-
tance genomic island harboring blaCMY−2 among clonally related
S. Typhimurium isolates (Shahada et al., 2011). Consequently,
the detection of blaCMY−2 in several S. Infantis isolates from
broilers poses another challenge in the veterinary public health
community. Carriers of blaCMY−2 harbored IncP plasmids
initially demonstrated in Pseudomonas bacteria (Shintani et al.,
2011).
Antimicrobial susceptibility data indicate a gradual decrease of
OFX resistance to 11.8 from 20.8% previously reported (Shahada
et al., 2010b). Fluoroquinolones (e.g., OFX) are broad-spectrum
antimicrobial agents widely used in clinical medicine. Emergence
of ﬂuoroquinolone resistance was attributed to overuse of this
groupof drugs indomestic animals either therapeutically or for the
purpose of growth promotion (Asai et al., 2007a). Since 1991, the
Japanese Ministry of Agriculture, Forestry and Fisheries (JMAFF)
approved this class of antimicrobials in veterinary medicine for
therapeutic purposes and prohibited its use as feed additives.
Fluoroquinolones might have been prescribed prudently among
antimicrobial agents used in broiler farms in Japan. This likely has
contributed to the decline of resistance to OFX observed in the
present study.
Taken together, these results show increased resistance against
ESCs mediated by both ESBLs and AmpC β-lactamases. It seems
these resistance traits have spread among farm animals in Japan
while their likely source remains largely unknown. The prob-
ability that resistance to ESCs may continue to spread among
members of the Enterobacteriaceae family poses another public
health challenge because ESBLs and AmpC β-lactamases limit the
effectiveness of cephalosporin therapy.
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